Protein engineering company, Codexis, has obtained a court order awarding a summary judgement of 10 claims of patent infringement against EnzymeWorks.
lawsuit
The court order has established the uncontested infringements of 10 of Codexis’ patents by EnzymeWorks and removes any need for a trial on these issues.
Codexis filed a lawsuit against EnzymeWorks early in 2016 in the US District Court for the Northern District of California in San Francisco, suing the founder of EnzymeWorks for willful infringement of 10 biocatalysis patents and for trade secret misappropriation, breach of contract, interference with business relationships and unfair competition.
Over the course of 18 months, EnzymeWorks did not contest the infringement charges or challenged the validity of Codexis’ patents, leading to the District Judge William H. Orrick awarding the summary judgment of patent infringement.
“Codexis is pleased to finally have some closure about EnzymeWorks’ blatant infringement of our patents and disrespect for US patent laws,” said John Nicols, CEO and president of Codexis. “Like our customers and shareholders, Codexis relies on intellectual property rights, and we are grateful that the legal process vindicated our claims and protects our innovations.”
This summary judgement order is a key milestone for Codexis in the lawsuit, however, additional disputes remain to be resolved at a jury trial.